Yi-Bin Chen, MD, an expert clinician and researcher, reviews a case study of a patient with GVHD and offers his initial impressions.
A 48-Year-Old Man with Chronic GVHD
An expert on graft-vs-host disease provides an overview of GVHD prophylaxis and conditioning regimens prior to transplant.
Yi-Bin Chen, MD, describes acute and chronic GVHD, and details the typical symptoms and presentations.
A comprehensive overview of the various treatment options for chronic graft-vs-host disease.
A summary of the systemic treatment options available for steroid-refractory chronic GVHD.
Yi-Bin-Chen, MD, discusses the effect of GVHD recurrence and multiple-organ involvement on treatment decisions.
Closing out his discussion on chronic graft-vs-host disease, Yi-Bin Chen, MD, looks to the future of GVHD treatment.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
